CONSISE -The consortium for the Standardization of Influenza Seroepidemiology -is a global partnership to develop influenza investigation protocols and standardize seroepidemiology to inform health policy. This international partnership was formed in 2011 and was created out of a need, identified during the 2009 H1N1 pandemic, for timely seroepidemiological data to better estimate pandemic virus infection severity and attack rates to inform policy decisions. CONSISE has developed into a consortium of two interactive working groups: epidemiology and laboratory, with a steering committee composed of individuals from several organizations. CONSISE has had two international meetings with more planned for 2013. We seek additional members from public health agencies, academic institutions and other interested parties.
During the 2009 influenza A(H1N1) pandemic (H1N1pdm09), seroepidemiological studies were undertaken to quantify the prevalence of pre-existing antibodies to and cumulative incidence of the new virus in the population, the proportion of infections that were asymptomatic and to estimate rates of infections in specific populations to inform decisions by policy makers on risk groups and the use of mitigation measures 1 . The results of dozens of seroepidemiological studies have become available in the past 2 years. [1] [2] [3] However, the majority of studies were performed subnationally based on convenience sampling, and many of the results emerged too late to be useful in informing policyrelated debates, issues and decisions, specifically those around understanding risk groups for vaccination and agespecific severity of the pandemic virus. [4] [5] [6] Additionally, despite many H1N1pdm09 seroepidemiological studies being undertaken, the direct comparability of results was limited due to a lack of standardization in the epidemiological data collected, and the laboratory methods used to assess the presence of cross-reactive antibodies to and cumulative incidence of the H1N1pdm09 virus. Furthermore, there were more general concerns over the difficulties in ensuring quality assurance for seroepidemiological studies in most laboratories. 3, 7 a partnership to develop best practices and standardize seasonal, pandemic and zoonotic influenza seroepidemiological methods. This partnership, now called CONSISEthe Consortium for the Standardization of Influenza Seroepidemiology - (Figure 1 ) held its first international meeting in Ottawa in January 2011 organized by PHAC. 8 The participants of the Ottawa meeting decided on a number of areas for improvement in conducting seroepidemiological studies including study design, prior laboratory and methodological standardization and laboratory quality assurance for serological assays. 8 A second international meeting was held in Stockholm in December 2011 hosted by ECDC. 9 Institutions including the WHO, ECDC, ICL, NIBSC, UKHPA, USCDC, UHK and WHOCC Melbourne played and are continuing to play key roles in the development of the work plan of CONSISE.
At the second international meeting in Stockholm, it was appreciated that considerable work needed to be undertaken to expand the scope of the work to encompass the development of protocols that will cover multiple objectives and functions around influenza and emerging respiratory infections. These objectives are being captured in the development of six generic seroepidemiological protocols for pandemic and epidemic influenza, seasonal influenza and zoonotic influenza (Table 1) 10 . Although generic, these protocols are being designed to be part of a comprehensive approach to include as much useful detail as possible, so that specific protocols for high-quality comparable studies can be produced with the fewest possible modifications. The six CONSISE protocols are based on existing influenza seroepidemiogical protocols, which have been used throughout the world (see Table 1 ). During both international meetings, it was appreciated that much joint work -both epidemiological and laboratory -is required in the areas of standardization, external quality assurance and cooperation to build on previous work in these areas to improve the quality of serological testing (Table 2) .
Under the leadership of an informal steering committee (see acknowledgements), the partnership has organized into laboratory and epidemiological working groups (Tables 1  and 2 outline current activities). The CONSISE steering committee consists of individuals from collaborating institutions in the consortium representing both laboratory and epidemiological influenza expertise and experience. The primary role of the steering committee is to ensure that the agreed work plan is enacted, specifically developing the protocols, undertaking laboratory work and preparing for the Options VIII conference in 2013. Core members of the steering committee are the conveners (EB and AN) together with the leaders of the protocol (MVK) and laboratory development (JW and OGE) aspects. ECDC will serve as the secretariat until the time of the Options VIII meeting in September 2013. There are numerous research institutions 
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ª 2012 Blackwell Publishing Ltd participating as members of the epidemiology and laboratory working groups, and the partnership is growing. Having set out many of the problems and offered some solutions in the first publication, 8 CONSISE has continued meeting via teleconferences and small focused face-to-face meetings. The next checkpoint will be a regional international meeting in Hong Kong in January 2013 with the presentation of the draft protocols from the epidemiological working group and results from the work plan of the laboratory working group. A 4th international meeting of CONSISE is being planned for the Options VIII Conference in September 2013 in Cape Town, South Africa.
Prior to the Options VIII conference, the protocols will undergo extensive revision and iteration with input from our many partners. We plan, at around the time of Options VIII, for the protocols to be made public in a draft format for open discussion, iteration and hopefully adoption with the wider scientific and public health community, with the intention to validate the protocols for seasonal and zoonotic influenza investigations prior to their use in a pandemic or the emergence of respiratory pathogens or emerging zoonoses. The CONSISE partnership welcomes interest in the partnership and comments on the protocols when available.
